On December 10, 2019, an agreement was reached between the United States, Mexico, and Canada on amendments to the U.S.-Mexico-Canada Agreement (“USMCA”). The USMCA, if ratified by each respective country, would replace the...more
12/18/2019
/ Biologics ,
Biotechnology ,
BPCIA ,
Copyright ,
Exclusivity ,
Exclusivity Rule ,
Foreign Entities ,
Intellectual Property Protection ,
NAFTA ,
Patent Term Extensions ,
Pharmaceutical Industry ,
Safe Harbors ,
Trade Associations ,
Trade Relations ,
United States-Mexico-Canada Agreement (USMCA)